SerratriceG., TogaM., RouxH., MuriascoA., and de BisschopG..: Neuropathies, Myopathies et Neuromyopathies Chez des Uremiques Chroniques.La Presse Medicale,75, 1835, 1967.
2.
FloydM., AyyarD.R., BarwickD.D., HudgsonP., and WeightmanD..: Myopathy in Chronic Renal Failure.Quarterly J. Med., XLIII, 509, 1974.
3.
LazaroR.P., and KirshnerH.S..: Proximal Muscle Weakness in Uremia.Arch. Neurol.,37, 555, 1980.
4.
BautistaJ., Gil-NecijaE., CastillaJ., ChinchonI., and RafelE..: Dialysis Myopathy. Report of 13 Cases.Acta Neuropathol.,61, 71, 1983.
5.
ShahA.J., SahgalV., QuintanillaA.P., SubramaniV., SinghH., and HughesR..: Muscle on Chronic Uremia — A Histochemical and Morphometric Study of Human Quadriceps Muscle Biopsies.Clin. Neuropathol.,2, 83, 1983.
6.
GalenR.S.: Creatine Kinase Isoenzyme BB in Serum of Renal-Disease Patients.Clin. Chem.,22, 120, 1976.
7.
WeseleyS.A., ByrnesA., AlterS., SolagiK.B., and GoodmaA.I..: Presence of Creatine Phosphokinase Brain Band in the Serum of Chronic Renal Disease Patients.Clin. Nephrol.,8, 345, 1977.
8.
CohenI.M., GriffithsJ., StoneR.A., and LeechT..: The Creatine Kinase Profile of a Maintenance Hemodialysis Population: a Possible Marker of Uremic Myopathy.Clin. Nephrol.,13, 235, 1980.
9.
NissensonA.: Personal Communication.
10.
BundschuH.D., and SchloteW..: Elektronenmikroskopische Untersuchungen der Skelettmuskulatur bei Terminaler Niereninsuffizienz.J. Neurol. Sci.,23, 243, 1974.
11.
BohmerT., BergremH., and EiklidK..: Carnitine Deficiency Induced during Intermittent Hemodialysis for Renal Failure.The Lancet, January21, 126, 1978.
12.
MingardiG., BizziA., CiniM., LiciniR., MeccaG., and GarattiniS..: Carnitine Balance in Hemodialyzed Patients.Clin. Nephrol.,13, 269, 1980.
13.
BellinghieriG., SavicaV., MallamaceA., Di StefanoC., ConsoloF., SpagnoliL.C., VillaschiS., PalmieriG., CorsiM., and MaccariF..: Correlation between Increased Serum and Tissue L-Carnitine Levels and Improved Muscle Symptoms in Hemodialyzed Patients.Am. J. Clin. Nutr.,38, 523, 1983.
14.
IsaacsH.: Electromyographic Study of Muscular Weakness in Chronic Renal Failure.So. Afr. Med. J.683, 1969.
15.
PatternB.M., BilezikianJ.P., MalletteL.E., PrinceA., EngelW., and AurbachG.D..: Neuromuscular Disease in Primary Hyperparathyroidism.Ann. Int. Med.,80, 182, 1974.
16.
SmithR., and SternG..: Myopathy, Osteomalacia and Hyperparathyroidism.Brain,90, 593, 1967.
17.
WardM.K., EllisH.A., FeestT.G., ParkinsonI.S., KerrD.N.S., HerringtonJ., and GoodeG.L..: Osteomalacic Dialysis Osteodystrophy: Evidence for a Water-Borne Etiological Agent, Probably Aluminum.The Lancet, April22, 841, 1978.
18.
PieridesA.M., EdwardsW.G.Jr., CullumU.X.Jr., McCallJ.T., and EllisH.A..: Hemodialysis Encephalopathy with Osteomalacic Fractures and Muscle Weakness.Kidney Intl.,18, 115, 1980.
19.
RasmussenH., and OgataE..: Parathyroid Hormone and the Reactions of Mitochondria to Cations.Biochem.,5, 733, 1966.
20.
GoodhueW.W., DavisJ.N., and PorroR.S..: Ischemic Myopathy in Uremic Hyperparathyroidism.JAMA,221, 911, 1972.
21.
RichardsonJ.A., HerronG., ReitzR., and LayzerR..: Ischemic Ulcerations of Skin and Necrosis of Muscle in Azotemic Hyperparathyroidism.Ann. Int. Med.,71, 129, 1969.
22.
RavidM., and RobsonM..: Proximal Myopathy Caused by Iatrogenic Phosphate Depletion.JAMA,236, 1380, 1976.
